Hydroxyapatite: An antibiotic recruiting moiety for local treatment and prevention of bone infections
Journal of Orthopaedic Research · 2024
DOI: 10.1002/jor.25650 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Orthopaedic Research, 2024. Verfasst von Sujeesh Sebastian und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, Orthopedics, Faculty of Medicine, Lund University, Lund, Sweden. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Osteomyelitis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Landshövding Per Westlings Minnesfond, Stina och Gunnar Wibergs Fond för Ortopedisk Forskning (Toffelfonden).
Abstract (Originalsprache)
Treatment of chronic osteomyelitis by radical debridement and filling of the dead space with antibiotic containing calcium sulfate/hydroxyapatite (CaS/HA) bone substitute has shown excellent long‐term outcomes. However, in extensive infections, sessile bacteria may remain in bone cells or soft tissues protected by biofilm leading to recurrences. The primary aim of this study was to evaluate if systemically administrated tetracycline (TET) could bind to pre‐implanted HA particles and impart an antibacterial effect locally. In vitro studies indicated that the binding of TET to nano‐ and micro‐sized HA particles was rapid and plateaued already at 1 h. Since protein passivation of HA after in‐vivo implantation could affect HA–TET interaction, we investigated the effect of serum exposure on HA–TET binding in an antibacterial assay. Although, serum exposure reduced the zone of inhibition (ZOI) of Staphylococcus aureus , a significant ZOI could still be observed after pre‐incubation of HA with serum. We could in addition show that zoledronic acid (ZA) competes for the same binding sites as TET and that exposure to high doses of ZA led to reduced TET–HA binding. In an in‐vivo setting, we then confirmed that systemically administered TET seeks HA particles that were pre‐implanted in muscle and subcutaneous pouches in rats and mice respectively, preventing HA particles from being colonized by S. aureus . Clinical Significance: This study describes a new drug delivery method that could prevent bacterial colonization of a HA biomaterial and reduce recurrences in bone infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Sciences, Orthopedics, Faculty of Medicine, Lund University, Lund, Sweden.
- Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden.
- Department of Clinical Sciences Lund, Dermatology, Faculty of Medicine, Lund University, Lund, Sweden.
ORCID-Profile: Deepak Bushan Raina
Förderung
- Landshövding Per Westlings Minnesfond
- Stina och Gunnar Wibergs Fond för Ortopedisk Forskning (Toffelfonden)
Zitieren
APA
Sebastian, S., Huang, J., Liu, Y., Tandberg, F., Collin, M., Puthia, M., & Raina, D. B. (2024). Hydroxyapatite: An antibiotic recruiting moiety for local treatment and prevention of bone infections. Journal of Orthopaedic Research. https://doi.org/10.1002/jor.25650
Vancouver
Sebastian S, Huang J, Liu Y, Tandberg F, Collin M, Puthia M, et al. Hydroxyapatite: An antibiotic recruiting moiety for local treatment and prevention of bone infections. Journal of Orthopaedic Research. 2024. doi:10.1002/jor.25650
BibTeX
@article{Sebastian2024,
author = {Sebastian, Sujeesh and Huang, Jintian and Liu, Yang and Tandberg, Felix and Collin, Mattias and Puthia, Manoj and Raina, Deepak Bushan},
title = {Hydroxyapatite: An antibiotic recruiting moiety for local treatment and prevention of bone infections},
journal = {Journal of Orthopaedic Research},
year = {2024},
doi = {10.1002/jor.25650}
}
EUVIMED